-
FasL incapacitation alleviates CD4+ T cells-induced brain injury through remodeling of microglia polarization in mouse ischemic stroke
Journal： Journal Of Neuroimmunology
引用产品：anti-COX-2 antibody()
ApplicationWB
IF3.125
SpeciesMouse
-
FasL incapacitation alleviates CD4+ T cells-induced brain injury through remodeling of microglia polarization in mouse ischemic stroke
Journal： Journal Of Neuroimmunology
引用产品：anti-GAPDH antibody()
ApplicationWB
IF3.125
SpeciesMouse
-
FasL incapacitation alleviates CD4+ T cells-induced brain injury through remodeling of microglia polarization in mouse ischemic stroke
Journal： Journal Of Neuroimmunology
引用产品：horseradish peroxidase (HRP)-conjugated secondary antibodies()
ApplicationWB
IF3.125
SpeciesMouse
-
FasL incapacitation alleviates CD4+ T cells-induced brain injury through remodeling of microglia polarization in mouse ischemic stroke
Journal： Journal Of Neuroimmunology
引用产品：chemiluminescence reagents()
Application
IF3.125
Species
-
New spirobisnaphthalenes from an endolichenic fungus strain CGMCC 3.15192 and their anticancer effects through the P53–P21 pathway
Journal： RSC Advances
引用产品：anti-β-actin antibody(AP0060)
ApplicationWB
IF3.119
SpeciesHuman
-
Harmane ameliorates obesity though inhibiting lipid accumulation and inducing adipocyte browning
Journal： RSC Advances
引用产品：anti-GAPDH antibody(AP0063/MB001)
ApplicationWB
IF3.119
SpeciesMouse
-
Discovery of methylpyrimidine ring-fused diterpenoid analogs as a novel testosterone synthesis promoter
Journal： RSC Advances
引用产品：Anti-CYP11A1 Antibody(BS6578)
ApplicationWB
IF3.119
SpeciesMouse
-
Livin participates in resistance to trastuzumab therapy for breast cancer through ERK1/2 and AKT pathways and promotes EMT-like phenotype
Journal： RSC Advances
引用产品：Anti-vimentin(BS1776)
ApplicationWB
IF3.119
SpeciesHuman
-
Livin participates in resistance to trastuzumab therapy for breast cancer through ERK1/2 and AKT pathways and promotes EMT-like phenotype
Journal： RSC Advances
引用产品：antiE-cadherin(BS1098)
ApplicationWB
IF3.119
SpeciesHuman
-
Livin participates in resistance to trastuzumab therapy for breast cancer through ERK1/2 and AKT pathways and promotes EMT-like phenotype
Journal： RSC Advances
引用产品：anti-N-cadherin(BS222)
ApplicationWB
IF3.119
SpeciesHuman
